Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Presented a poster highlighting the use of the Company's Magellan™ drug discovery platform to identify allosteric inhibitors ...

Life Sciences announced today that it is building on OFD's 60 plus years of lyophilization expertise with multiple leadership appointments to its recently created Life Sciences division and the ...

The National Kidney Foundation (NKF) has awarded Jayme Locke, MD, MPH, FACS, FAST, Vice President, Medical Development, ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "Servier's commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. “Servier’s commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

Building a climate-controlled warehouse and logistics facility for United Therapeutics in North Carolina’s Research Triangle was a matter of power management and careful planning. The facility ...